Date Filed | Type | Description |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2023 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 109 shares
@ $2.6, valued at
$283.4 Sold 96 shares
@ $2.36, valued at
$226.6 Sold 98 shares
@ $2.41, valued at
$236.2 Bought 17,702 shares
@ $1.52, valued at
$26.9k
|
|
03/07/2023 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 48 shares
@ $7.49, valued at
$359.5 Sold 110 shares
@ $7.4906, valued at
$824 Sold 157 shares
@ $13.29, valued at
$2.1k
Sold 103 shares
@ $4.25, valued at
$437.8 |
|
12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/06/2022 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 5,809 shares
@ $0.2807, valued at
$1.6k
Sold 2,484 shares
@ $0.2812, valued at
$698.5 |
|
09/12/2022 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 4,828 shares
@ $0.39, valued at
$1.9k
|
|
08/26/2022 |
3
| Hickey Paul F. (President and CEO) has filed a Form 3 on ReShape Lifesciences Inc. |
08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 5,038 shares
@ $1.13, valued at
$5.7k
|
|
04/08/2022 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 11,063 shares
@ $1.13, valued at
$12.5k
|
|
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 6,538 shares
@ $1.06, valued at
$6.9k
|
|
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/28/2022 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 7,150 shares
@ $1.79, valued at
$12.8k
|
|
01/28/2022 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 3,171 shares
@ $1.78, valued at
$5.6k
|
|
12/09/2021 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 13,427 shares
@ $1.83, valued at
$24.6k
|
|
12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2021 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Bought 20,000 shares
@ $2.02, valued at
$40.4k
|
|
11/16/2021 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 13,505 shares
@ $2.69, valued at
$36.3k
|
|
11/16/2021 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 4,320 shares
@ $2.69, valued at
$11.6k
|
|
10/12/2021 |
4
| STANKOVICH THOMAS (CFO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 3,660 shares
@ $2.76, valued at
$10.1k
|
|
10/12/2021 |
4
| Bandy Barton P. (President and CEO) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Sold 12,565 shares
@ $2.77, valued at
$34.8k
|
|
09/17/2021 |
4
| BLACKFORD GARY (Director) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Granted 253,429 shares
@ $0 |
|
09/17/2021 |
4
| MINOCHERHOMJEE ARDA PHD (Director) has filed a Form 4 on ReShape Lifesciences Inc.
Txns:
| Granted 253,429 shares
@ $0 |
|
|